Compound Detail
CHEMBL373742
VASOPRESSIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O
Basic Information
| ChEMBL ID | CHEMBL373742 |
| Name | VASOPRESSIN |
| Phase | Approved |
| Structure Type | BOTH |
| InChI Key | KBZOIRJILGZLEJ-LGYYRGKSSA-N |
| Therapeutic | ✓ Yes |
11
Targets
63
Activities
4
Assay Types
5
PK Parameters
20
Publications
12
Known Names
20
Indications
1
Mechanisms
Molecular Properties
1084.2
MW (Da)
Drug Information
| Molecule Type | Protein |
| First Approval | 2014 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Vasopressin receptor agonist | AGONIST | Vasopressin receptor | ✓ | ✓ |
Indications
Diabetes Insipidus Sepsis Heart Arrest Heart Diseases Myoma Pain Shock Shock, Septic Syndrome Acute Lung Injury Autistic Disorder Child Development Disorders, Pervasive Death, Sudden, Cardiac Depressive Disorder, Major Hernias, Diaphragmatic, Congenital Hypertension, Pulmonary Leiomyoma Pleural Effusion Abortion, Spontaneous Hypotension
Activity Summary
EC50 27 meas. best 10.3
Ki 27 meas. best 9.59
Kd 6 meas. best 9.19
IC50 3 meas. best 8.48
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vasopressin V2 receptor CHEMBL1790 | EC50 | 10.3 | 9.716 | 0.1 | 5 |
| Vasopressin V1a receptor CHEMBL2868 | EC50 | 10.2 | 10.175 | 0.1 | 2 |
| Oxytocin receptor CHEMBL2049 | EC50 | 10.0 | 8.1283 | 0.1 | 6 |
| Vasopressin V1a receptor CHEMBL1889 | EC50 | 9.63 | 9.112 | 0.2 | 5 |
| Vasopressin V1a receptor CHEMBL1889 | Ki | 9.59 | 9.0027 | 0.3 | 11 |
| Vasopressin V1b receptor CHEMBL2659 | Ki | 9.54 | 9.54 | 0.3 | 1 |
| Vasopressin V2 receptor CHEMBL3766 | Ki | 9.35 | 9.35 | 0.5 | 1 |
| Vasopressin V1b receptor CHEMBL1921 | Ki | 9.31 | 9.06 | 0.5 | 3 |
| Vasopressin V1a receptor CHEMBL2868 | Kd | 9.19 | 9.19 | 0.6 | 2 |
| Vasopressin V1 receptor CHEMBL2095221 | Kd | 9.19 | 9.19 | 0.7 | 2 |
| Oxytocin receptor CHEMBL3996 | Ki | 8.93 | 8.93 | 1.2 | 1 |
| Vasopressin V2 receptor CHEMBL1790 | Ki | 8.92 | 8.53 | 1.2 | 4 |
| Vasopressin V2 receptor CHEMBL2344 | Kd | 8.82 | 8.82 | 1.5 | 1 |
| Vasopressin V2 receptor CHEMBL3766 | Kd | 8.82 | 8.82 | 1.5 | 1 |
| Vasopressin V1a receptor CHEMBL2868 | Ki | 8.81 | 8.81 | 1.5 | 1 |
| Oxytocin receptor CHEMBL2049 | Ki | 8.78 | 8.478 | 1.6 | 5 |
| Vasopressin V1b receptor CHEMBL1921 | EC50 | 8.7 | 7.9314 | 2.0 | 7 |
| Vasopressin V2 receptor CHEMBL3944 | IC50 | 8.48 | 8.48 | 3.3 | 1 |
| Vasopressin V1 receptor CHEMBL2095221 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Vasopressin V2 receptor CHEMBL1790 | IC50 | 6.62 | 6.62 | 242.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | - | - | Rattus norvegicus |
| T1/2 | 1.7 | hr | Homo sapiens |
| T1/2 | 24.0 | hr | - |
| T1/2 | 0.05 | hr | - |
| Vd | 0.067 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine